SYNGENE - Trademark Details
Status: 700 - Registered
Serial Number
88081490
Registration Number
6531176
Word Mark
SYNGENE
Status
700 - Registered
Status Date
2021-10-19
Filing Date
2018-08-16
Registration Number
6531176
Registration Date
2021-10-19
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2020-01-14
Attorney Name
Law Office Assigned Location Code
M70
Employee Name
BRACEY, KAREN E
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the word "Syngene" in stylized font.
Goods and Services
Biotechnological products and preparations for laboratory use, namely, enzymes, protein carbohydrates, lipids, and nucleic acids, DNA products, immunological re-agents, and fine chemicals including organic intermediates; active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions, involving areas namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; assays for research purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; unprocessed chemical polymers; chemicals for use in biotechnological product development; chemicals, namely, chitosan; chitosan for industrial purposes; aldehydes; chromatography chemicals; cells for scientific, laboratory or medical research; reagents for use in the development of hybridoma antibodies for other than for medical or veterinary purposes; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; protein arrays and nucleotide arrays for scientific and medical research; peptides for industrial purposes; proteins for use in recombinant DNA technology; specialty chemicals, namely, chemical additives for industrial use in the manufacture of a wide variety of oods; chemical reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for use in vitro scientific or research; assays for research purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes
Goods and Services
Biological and biotechnological chemicals and chemical preparations and formulations thereof for pharmaceutical and medical use; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; antibodies for use in disease testing; synthetic peptides for pharmaceutical purposes; imaging agents for magnetic resonance imaging ; nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biological tissue grafts; vascular grafts comprised of living tissue; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medical, veterinary or pharmaceutical purposes; proteins and protein arrays for use in recombinant DNA technology for medical and diagnostic purposes; regulatory proteins for medical and diagnostic use; medicines for veterinary purposes; isotopes for medical purposes; biological preparations for medical purposes for treating disease and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, meningitis, asthma; chemical preparations for use in medical DNA analysis for diagnostic and treatment purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes
Goods and Services
BIOREACTORS FOR LABORATORY USE
Goods and Services
SURGICAL, MEDICAL, DENTAL AND VETERINARY INSTRUMENTS AND APPARATUS, namely, ARTIFICIAL LIMBS EYES AND TEETH
Goods and Services
Paper and paper articles, namely, writing paper, notebooks, sketch pads, letterhead paper, envelopes, file folders, printed brochures, leaflet, informational flyers and pamphlets in the field of science, biology, genetics, chemistry, formulations, antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; printers type and printing clichés, namely, stereotypes; directories in the field of science, biology, genetics, chemistry, formulations, antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; printed sign boards, banners, table calendars, and printed certificates; pens and pencils; cardboard and cardboard articles, namely, boxes, packing material, containers, and paper bags; printed matter in the nature of newspapers for general circulation; periodicals in the nature of general features magazines; books in the field of science; bookbinding materials; printed photographs; stationery; adhesive materials for stationery and office use; artists materials, namely, paint, drawing paper, canvas, pens; paint brushes; typewriters and office requisites other than furniture, namely, rubber bands, staplers, paper hole-punches, pen stands, adhesive note paper; printed instructional and teaching materials other than apparatus in the field of science, biology, genetics, chemistry, formulations, antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; printers type and printing clichés, namely, stereotypes; directories in the field of science, biology, genetics, chemistry, formulations, antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; blank journals; printed training materials in the field of clinical study, medical writing and pharmacovigilance services; none of the aforesaid goods relating to gel imaging and gel analysis applications; none of the aforesaid goods used for packaging of agrochemical products and seeds
Goods and Services
Business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, large molecule development, antibody drug conjugates and clinical development services; consulting services in the field of medical practice management for others; business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business management consulting services in the field of pharmaceuticals drug development; none of the aforesaid services relating to gel imaging and gel analysis applications
Goods and Services
STORAGE OF HUMAN CELLS
Goods and Services
Treatment of materials by polymerization; custom manufacture of pharmaceuticals, chemotherapy drugs, antibiotic medicines, medicines, drugs by pharmaceutical compounders; contract manufacturing in the field of pharmaceuticals and drug development
Goods and Services
Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials; conducting clinical trials for scientific research for others; conducting clinical trials for pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; toxicokinetic analysis and toxicology services; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, genes, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications, and none of the aforesaid services in the field of agriculture, horticulture and forestry
Goods and Services
Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes; behavioral analysis in response to chemicals for medical purposes
Classification Information
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2018-08-25
Primary Code
040
First Use Anywhere Date
2004-08-31
First Use In Commerce Date
2004-08-31
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-08-25
Primary Code
044
First Use Anywhere Date
2004-08-31
First Use In Commerce Date
2004-08-31
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Lawrence E. Abelman
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Child | 88981754 |
Trademark Events
Event Date | Event Description |
2018-08-20 | NEW APPLICATION ENTERED IN TRAM |
2018-08-25 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-12-03 | ASSIGNED TO EXAMINER |
2018-12-06 | NON-FINAL ACTION WRITTEN |
2018-12-06 | NON-FINAL ACTION E-MAILED |
2018-12-06 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-06-04 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-06-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-06-04 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-06-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2019-06-11 | NON-FINAL ACTION WRITTEN |
2019-06-11 | NON-FINAL ACTION E-MAILED |
2019-06-11 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-12-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-12-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-12-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-12-12 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-12-25 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-01-14 | PUBLISHED FOR OPPOSITION |
2020-01-14 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-02-11 | EXTENSION OF TIME TO OPPOSE RECEIVED |
2020-06-02 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
2020-06-24 | ASSIGNED TO PETITION STAFF |
2020-06-26 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
2020-07-23 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
2020-09-01 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-03-01 | TEAS EXTENSION RECEIVED |
2021-03-01 | EXTENSION 1 FILED |
2021-03-01 | EXTENSION 1 GRANTED |
2021-03-03 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-05-06 | TEAS REQUEST TO DIVIDE RECEIVED |
2021-05-26 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-05-06 | DIVISIONAL REQUEST RECEIVED |
2021-05-26 | DIVISIONAL PROCESSING COMPLETE |
2021-09-01 | TEAS STATEMENT OF USE RECEIVED |
2021-09-01 | USE AMENDMENT FILED |
2021-09-08 | STATEMENT OF USE PROCESSING COMPLETE |
2021-09-16 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2021-09-17 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2021-10-19 | REGISTERED-PRINCIPAL REGISTER |